GQG Partners LLC reduced its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 98.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,356 shares of the financial services provider’s stock after selling 2,044,609 shares during the period. GQG Partners LLC’s holdings in CME Group were worth $6,585,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Truvestments Capital LLC acquired a new stake in shares of CME Group during the third quarter worth $26,000. SJS Investment Consulting Inc. lifted its position in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC grew its stake in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners acquired a new position in shares of CME Group in the fourth quarter valued at about $32,000. Finally, Knuff & Co LLC purchased a new position in shares of CME Group in the fourth quarter worth about $33,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Down 0.2 %
CME opened at $262.94 on Tuesday. The company has a market cap of $94.75 billion, a PE ratio of 27.19, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $267.91. The company has a 50-day moving average price of $247.17 and a 200 day moving average price of $234.65. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.
CME Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. CME Group’s dividend payout ratio is presently 51.71%.
CME Group announced that its board has approved a stock buyback plan on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board believes its shares are undervalued.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on CME shares. Barclays increased their price target on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a report on Monday, March 17th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. Finally, Morgan Stanley upped their target price on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $238.93.
Get Our Latest Stock Analysis on CME
Insider Transactions at CME Group
In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now directly owns 21,873 shares of the company’s stock, valued at $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last 90 days. 0.30% of the stock is currently owned by corporate insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- What is the S&P/TSX Index?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Investing in the High PE Growth Stocks
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Stock Analyst Ratings and Canadian Analyst Ratings
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.